bluebird bio, Inc. (117) | Business Finance (11)
Browse by Subcategory
Recent Contracts
-
Underwriting Agreement, dated as of January 18, 2023, by and among bluebird bio, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC
(Filed With SEC on January 19, 2023)
-
Asset Purchase Agreement, dated as of January 5, 2023, by and between bluebird bio, Inc. and Bristol-Myers Squibb Company
(Filed With SEC on January 6, 2023)
-
Asset Purchase Agreement, dated as of November 29, 2022, by and between bluebird bio, Inc. and argenx BV
(Filed With SEC on November 30, 2022)
-
Equity Distribution Agreement, dated as of June 22, 2022, by and between bluebird bio, Inc. and Goldman Sachs & Co. LLC
(Filed With SEC on June 22, 2022)
-
Securities Purchase Agreement, dated September 7, 2021, by and among the Registrant and the institutional investors named therein
(Filed With SEC on November 5, 2021)
-
Registration Rights Agreement, dated September 7, 2021, by and among the Registrant and the persons listed on the attached Schedule A thereto
(Filed With SEC on November 5, 2021)
-
Form of Pre-Funded Warrant
(Filed With SEC on September 8, 2021)
-
Securities Purchase Agreement, dated September 7, 2021, by and among the Company and the institutional investors named therein
(Filed With SEC on September 8, 2021)
-
Registration Rights Agreement, dated September 7, 2021, by and between the Company and the persons listed on the attached Schedule A thereto
(Filed With SEC on September 8, 2021)
-
First Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment...
(Filed With SEC on August 5, 2020)
-
Underwriting Agreement, dated as of May 18, 2020, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC, as representatives of the...
(Filed With SEC on May 19, 2020)